Priyal V. Bagwe, Ph.D. (she/her/hers)

Post Doc
US Food and Drug Administration

Poster(s):

• (M1130-03-17) Enhancing Gonorrhea Vaccine Efficacy: Dosage Response Analysis of a Novel Microparticulate Formulation
  Monday, October 21, 2024

  11:30 AM – 12:30 PM MT

• (M1130-06-36) A Cell-To-Cell Contact Immune System Mimicking In Vitro Overlay Assay: Evaluating Nanoparticle Vaccine Formulations for Adaptive Immunity Responses
  Monday, October 21, 2024

  11:30 AM – 12:30 PM MT